News

Theses · Events · Sentiments

24-08-09

Eli Lilly's innovative drug developments set it apart in the pharmaceutical industry. The company …

24-08-08

Eli Lilly & Co. (NYSE:LLY) reported exceptionally strong second-quarter earnings for fiscal Q2 2024, …

24-09-11 17.80%

These two drugmakers have been delivering significantly above-average returns for years. Both still have excellent prospects and could decide to …

24-08-27 -8.60%

Eli Lilly released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price …

24-08-22 20.00%

Eli Lilly's sales rose by 36% last quarter to $11.3 billion. The company's low cost of sales has boosted its …

24-08-20 -38.80%

Eli Lilly's weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults …

24-08-19 12.60%

Novo Nordisk and Eli Lilly won't be constrained by manufacturing too much longer. That means they'll sell more of their …